GRN and neoplasm: Many studies have demonstrated the efficacy of progranulin-inhibition in reducing in vitro tumor cell proliferation, migration and invasion, as well as in vivo tumor formation in multiple tumor models, as reviewed by Arechavaleta-Velasco et al. [74].